|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.59 USD | -.--% |
|
+2.93% | -10.44% |
| Mar. 21 | Cibus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 21 | Transcript : Cibus, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Cibus, Inc. entered into investment agreement with AstraZeneca PLC to subscribe for 16,000,000 ordinary shares at a price of $5 per share for gross proceeds of $80 million on November 01, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.44% | 343M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
CALYXTPAR 
